tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luke Sergott, 39 are a HOLD (19.4%), 145 are a BUY (72.14%), 17 are a SELL (8.46%).
Analyst Luke Sergott, currently employed at BARCLAYS, carries an average stock price target met ratio of 57.13% that have a potential upside of 13.74% achieved within 108 days.
Luke Sergott’s has documented 452 price targets and ratings displayed on 17 stocks. The coverage is on Basic Materials, Healthcare sectors.
Most recent stock forecast was given on TWST, Twist Bioscience Corp at 19-Nov-2024.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for SHC (SOTERA HEALTH CO) at 11/15/2022. The price target of $6 was fulfilled within 2 days with a profit of $0.97 (13.92%) receiving and performance score of 69.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$28
$7.38 (35.79%)
$28
26 days ago
(28-Oct-2024)
3/5 (60%)
$5.36 (23.67%)
219
Buy
$25
$4.38 (21.24%)
$28
29 days ago
(25-Oct-2024)
13/22 (59.09%)
$2.57 (11.46%)
142
Buy
$29
$8.38 (40.64%)
$22
3 months 25 days ago
(29-Jul-2024)
5/10 (50%)
$2.75 (10.48%)
138
Buy
$28
$7.38 (35.79%)
$28
3 months 25 days ago
(29-Jul-2024)
3/6 (50%)
$1.75 (6.67%)
97
Buy
$27
$6.38 (30.94%)
$28
4 months 21 days ago
(02-Jul-2024)
4/8 (50%)
$6.42 (31.20%)
28
Which stock is Luke Sergott is most bullish on?
Which stock is Luke Sergott is most reserved on?
What Year was the first public recommendation made by Luke Sergott?
